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Abstract
Background: There is a considerable interest in characterizing the biological role of specific
protein residue substitutions through mutagenesis experiments. Additionally, recent efforts related
to the detection of disease-associated SNPs motivated both the manual annotation, as well as the
automatic extraction, of naturally occurring sequence variations from the literature, especially for
protein families that play a significant role in signaling processes such as kinases. Systematic
integration and comparison of kinase mutation information from multiple sources, covering
literature, manual annotation databases and large-scale experiments can result in a more
comprehensive view of functional, structural and disease associated aspects of protein sequence
variants. Previously published mutation extraction approaches did not sufficiently distinguish
between two fundamentally different variation origin categories, namely natural occurring and
induced mutations generated through in vitro experiments.
Results: We present a literature mining pipeline for the automatic extraction and disambiguation
of single-point mutation mentions from both abstracts as well as full text articles, followed by a
sequence validation check to link mutations to their corresponding kinase protein sequences. Each
mutation is scored according to whether it corresponds to an induced mutation or a natural
sequence variant. We were able to provide direct literature links for a considerable fraction of
previously annotated kinase mutations, enabling thus more efficient interpretation of their
biological characterization and experimental context. In order to test the capabilities of the
presented pipeline, the mutations in the protein kinase domain of the kinase family were analyzed.
Using our literature extraction system, we were able to recover a total of 643 mutations-protein
associations from PubMed abstracts and 6,970 from a large collection of full text articles. When
compared to state-of-the-art annotation databases and high throughput genotyping studies, the
mutation mentions extracted from the literature overlap to a good extent with the existing
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previously annotated in the databases.
Conclusion: Using the proposed residue disambiguation and classification approach, we were able
to differentiate between natural variant and mutagenesis types of mutations with an accuracy of
93.88. The resulting system is useful for constructing a Gold Standard set of mutations extracted
from the literature by human experts with minimal manual curation effort, providing direct pointers
to relevant evidence sentences. Our system is able to recover mutations from the literature that
are not present in state-of-the-art databases. Human expert manual validation of a subset of the
literature extracted mutations conducted on 100 mutations from PubMed abstracts highlights that
almost three quarters (72%) of the extracted mutations turned out to be correct, and more than
half of these had not been previously annotated in databases.
Background
Protein kinases are the most ubiquitous family of signal-
ing molecules in human cells, accounting for approxi-
mately 2% of the proteins encoded by the human genome
[1]. They can be further divided into sub-families that
share significant similarity both at the sequence and struc-
tural level. A common feature of all kinases is their ability
to transfer the terminal phosphate of ATP to serine, thre-
onine or tyrosine residues of a target protein. Empirical
studies also suggest a common catalytic mechanism
whereby ATP and active site divalent cations are bound as
well, and phospho-transfer is carried out by a shared set of
amino acids. Despite these functional commonalities,
experiments in yeast models [1,2] suggest that the protein
kinase family as a whole is highly promiscuous, phospho-
rylating a range of different protein substrates, although
individual sub-families may display a remarkable sub-
strate specificity [3]. Kinases have a domain committed to
the general function of catalysis, while another region (or
even regions) are used in many cases to confer substrate
specificity to the enzyme, without altering the general
kinase folding, interfering with ATP binding or the general
reaction mechanism. For reviews on the evolution of
kinase structure and function see [4-7]. Several efforts
have been made to provide a comprehensive access to
information relevant to characterize human protein
kinases through specific databases such as KinBase [1],
KinMutBase [8] and MoKCa [9], or more general data-
bases like PDB [10], PFAM [11] and CATH [12], storing
information important to understand disease-association,
functional and structural properties of kinases.
The relation of kinases with a number of diseases [13] and
in particular with cancer [14-16] has prompted a number
of large scale studies, in particular, Greenman et al. carried
out the first large scale study of the variation associated
with 518 protein kinase genes in 210 samples of cancer
tissues and cell lines. Other HT studies not specifically
restricted to kinases have obviously also contributed in
understanding and providing information on mutations
in protein kinases [14,15]. The interest of kinases and
their implication in disease processes has continued with
the study of Sjöblom and colleagues [15]. For a detailed
review refer to Baudot et al. [17].
The sizeable amounts of information provided by large
scale variation studies and the growing efforts of data-
bases and resources to store and curate this information,
are still not perfectly/completely connected with the many
efforts dedicated to the detailed study of specific kinases
in various biological systems [18] published in individual
research papers. For instance, it is still a challenging task
to establish for which individual mutations detected in
HT studies there is already available information in the lit-
erature. Manual inspection and curation of specific varia-
tion studies and the exact linking to the textual
information requires considerable resources.
Despite difficulties in extracting more complex language
expressions referring to mutation mentions, regularities in
describing mutations based on existing nomenclature
conventions, promoted the implementation of auto-
mated information extraction and text mining systems for
the identification of mutations in the literature [19-30].
Table 1 provides a short summary of previously published
literature mining efforts for mutation information extrac-
tion.
Even though most of the existing manually curated muta-
tion annotation resources are based on reading full text
articles, existing automated systems mainly relied only on
(subsets of) PubMed abstracts or a small collection of full
text articles. To facilitate the interpretation of the biologi-
cal implications and phenotypic effects of a given muta-
tion, not only by clinical experts but also by database
curators or for designing biochemical experiments (drug
design and molecular functional studies) it is crucial to
know whether a given mutation has been experimentally
generated or is present in a naturally occurring sequence
variation. This aspect has generally been neglected by pre-
viously developed approaches. Finally, only few systems
were able to show results based on the combination ofPage 2 of 20
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sources, derived from literature as well as based on exper-
imental data generated by genotyping studies.
Here we examined the use of text mining methods to
extract information from the literature about protein
kinases and their specific mutations, link this information
to the corresponding protein sequences from databases
(normalization) and analyze how this information is dis-
tributed in protein kinases related databases and reposi-
tories. The results of comparing information from
databases and text repositories are analyzed in terms of
the quality of the information provided and the signifi-
cance in terms of the knowledge related to PK structure
and function. We therefore applied an available mutation
extraction system, called MutationFinder [23] to the
whole collection of abstracts contained in PubMed data-
base as well as to a large set of automatically retrieved full
text articles. To determine if a putative mutation mention
really corresponds to a mutation or actually to something
else we developed a module that allows filtering of false
positive mutation mentions through a combination of
named entity recognition, dictionary look-up and rule
based methods. A supervised machine learning method
relying on the SVM algorithm was used to score and clas-
sify based on its context whether a given mutation men-
tion correspond to an experimentally generated (induced)
mutation or is a natural sequence variant. A protein men-
tion normalization system together with an mutation
sequence checking approach was used to detect associa-
tions between mutations and human kinases co-cited in
the literature. Validation and comparison to multiple
existing mutation resources, including the SwissProt data-
base [31] as well as the COSMIC [32], Greenman/Wood
dataset of somatic mutations [14,16], KinMutBase [8],
and SAAPdb databases [33]. The extraction and compara-
tive mutation analysis were followed by a structural exam-
ination of the distribution of the different type of
mutations in kinase regions of structural and functional
importance.
Results and discussion
Here we present a workflow for extracting mutations
within human protein kinases. The pipeline integrates
article retrieval, detection of mutations mentioned in the
literature, and a final validation of mutations linked to
their corresponding protein sources. We carried out a
comparative analysis of multiple annotation resources
containing different mutation types. An overview of the
resulting approach is presented in figure 1, illustrating the
main steps of the mutation extraction pipeline.
Systematic extraction and disambiguation of mutation 
mentions
For the initial extraction of single amino acid substitu-
tions we applied the MutationFinder system, a modular
software for point mutation recognition based on regular
expressions and patterns detecting mutation mentions
corresponding to residue abbreviations as well as other
language expressions used to describe mutation events
[34]. This system shows a competitive performance in
terms of recall/precision when compared to other strate-
gies [28] and has been evaluated using a manually gener-
ated Gold Standard collection of abstracts [23].
We applied the MutationFinder tool to the whole PubMed
database (November 2008), resulting in the detection of
302,956 mutation mentions from 88,405 records, corre-
sponding to a total of 61,329 unique mutation types (i.e.
wild type residue, sequence position and mutant residue
triplets). A more detailed analysis of the most frequent
mutation types (see additional file 2), illustrated the
importance of the Cystein to Tyrosine mutation in posi-
tion 282 (C282Y, corresponding to the
dbSNP:rs1800562) and the Histidine to Aspartic Acid
mutation at position 63 (H63D, dbSNP:rs1799945), both
occurring in the hereditary hemochromatosis protein
(HFE, SwissProt:Q30201), known to be associated to sev-
eral human diseases. These two mutations are mentioned
over 3,500 and 1,900 times respectively. Some of the most
frequent mutation types corresponded to cases of false
positive (ambiguous) mutations mentions that actually
consisted in names of cell lines (T47D cells) or mouse
strains (G93A mouse model).
As the MutationFinder system was developed and evalu-
ated using a collection of abstracts known to be relevant
for mutations, primarily derived from citations related to
mutant protein structures from the Protein Data Bank
(PDB), we carried out a coarse level consistency analysis
to determine how scalable this system is when applied to
the whole PubMed database, where many articles do not
necessarily resemble the data collection used for the initial
system development. Assuming that the overall mutation
types, contained in manually annotated resources like the
SwissProt database should be similar to the ones encoun-
tered throughout PubMed we compared mutations
extracted automatically from the literature to information
contained in SwissProt, namely mutations being anno-
tated as either natural variant, induced (mutagenesis) or
both single amino acid substitutions. A comparative anal-
ysis of the frequencies of annotated mutation pairs (wild
type residue and the associated mutation) showed that
there are considerable differences between the mutations
often encountered in naturally occurring variations as
opposed to experimentally induced amino acid changes.
The overall profiles resulting from the relative percentagesPage 3 of 20
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figure 2A), despite existing differences encountered in
terms of the most frequent mutations pairs extracted
through text mining when compared to manual annota-
tions (figure 2B).
The most remarkable differences in case of the relative fre-
quencies of mutation types extracted from PubMed com-
pared to SwissProt corresponded to mutations formed by
the residues, A, T, C and G (i.e. G-T, C-T, A-G and T-A sub-
stitutions). This is due to the intrinsic ambiguity of single
letter mutation mentions that can correspond to both
mutations at the DNA or protein level depending on the
context. In order to distinguish between these two muta-
tion levels, additional processing would be required. A
more detailed analysis of the wild type residue and the
mutant residue frequencies revealed that automatically
extracted mutation residues are in line from what would
be expected when examining the relative frequencies
within a manually curated database (figure 3A and 3B).
The most frequently mutated residues mentioned in
PubMed are Arginine, Glycine and Serine, corresponding
also to the top ranking ones annotated in SwissProt.
SwissProt shows more variability when comparing anno-
tations of wild type residues from naturally to induced
variations. In case of experimentally generated mutations,
the residues most frequently replaced are Serines, Lysines,
Arginines, Cysteines and Tyrosines, corresponding to
functionally important residues. Considering the mutant
residues, the literature mining extracted residues are con-
sistent with the mutant residues from SwissProt, which
shows great variation in case of Alanine induced and nat-
ural variant mutants. This can be explained by the wide-
spread use of experimental approaches relying on the
Alanine scanning method for identifying functionally rel-
evant sites, as substitutions to Alanine usually still allow
protein folding yet may give an altered phenotype. A more
detailed description of the mutation disambiguation and
filtering approach to remove false positive mutation men-
tions is provided in the method section.
Scoring variation origin categories: artificial and natural 
mutations
For extraction and management of biological annotations
and to carry out functional analysis of mutations it is cru-
cial to know the level of granularity and experimental con-
text used for determining the phenotypic effect of a given
amino acid substitution. The SwissProt database distin-
guishes here between induced or artificial (mutagenesis)
Table 1: Literature mining approaches for mutation extraction. The additional materials sections (Additional file 1) provides a more 
detailed description of each method.
Collection of existing mutation extraction approaches
Method Main characteristics and descriptive 
keywords of the approach
Ref
MEMA Uses regular expressions, gene and protein 
mention detection, co-mention proximity, 
OMIM validation
[19]
MuteXt Uses regular expressions, GPCR and NR 
mention detection, co-mention proximity, 
sequence check
[27]
Yip et al. Uses regular expressions, protein mention 
detection, SwissProt validation, extensive 
sequence check
[28]
CoagMDB Uses regular expressions, serine protease 
mention detection, sequence check
[41]
Mutation GraB Uses regular expressions, protein mention 
detection, graph shorted distance, sequence 
check
[20]
Mutation Miner Uses regular expressions, protein mention 
detection, sentence co-mention
[21]
MuGeX Uses regular expressions, protein mention 
detection, protein and DNA mutation 
disambiguation
[24]
VTag Machine learning (CRF) detection of acquired 
sequence variations mentions (mutations, 
translocations, deletions)
[26]
OSIRISv1.2 Detection of human gene variations 
corresponding to SNPs
[42]
MutationFinder Uses regular expressions and patterns, protein 
mutations, complex language expressions
[23]Page 4 of 20
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to less than 13 percent of the mutation annotations. Char-
acterizations at the level of molecular functional implica-
tions and sub-cellular interactions of specific residues are
commonly studied through experimentally induced
amino acid changes. On the other hand associations to
diseases such as certain cancer types and relevance for
population groups or patients of a given mutation is usu-
ally studied by examining naturally occurring sequence
variants. To address this important issue, allowing muta-
tion mention scoring for each of these two basic categories
of phenotypic descriptions we applied a supervised
machine learning strategy for mutation sentence classifi-
cation. We applied a SVM algorithm (using radial basis
function as kernel) trained on a balanced sample set of
3,482 (71%) labeled sentences for induced and natural
variant mutations and evaluated it on an independent test
set of 1,400 sentences (29%), obtaining an accuracy of
94.64 (recall: 94.57 and precision of 94.71) on this collec-
tion. The size of the feature dictionary used by the classi-
fier was of 11,803 word types (unique words, not
stemmed). A manual inspection of the generated feature
dictionary revealed that some of the relevant features cor-
responded to terms comprised in experimental tech-
niques used to generate artificial mutations, such as site-
directed mutagenesis. This basic evaluation schema is
suitable to determine the performance on a controlled set
of balanced instances, but does not take into account the
actual distribution of the classes within a large collection
of unlabelled data nor cases that even by human experts
can not be clearly classified into one of these binary cate-
gories. Therefore we carried out both, a classification con-
sistency analysis on the resulting sentence scores as well as
a detailed evaluation and comparison against manually
examined mutation sentences (see figures 4A to 4F).
To determine the overall classification and scoring con-
sistency on the level of the whole mutation sentence col-
lection extracted from PubMed described in the previous
subsections, we analyzed the distribution of a database
confirmed set of natural variant mutations against a ran-
domly chosen set of mutation mentions. The first collec-
tion of sentences corresponded to mutation mentions
cross-checked from SwissProt annotations as natural vari-
ants, resulting in a total of 10,886 sentences, none of these
were contained in the original training nor test set. The
second collection was constructed by randomly selecting
an equal number of mutation mentioning sentences from
PubMed abstracts. For each of these two sets we deter-
mined the corresponding sentence scores generated by the
classifier. Figure 4A shows the box plot of the sentence
classifier scores for the 10,886 natural variant mutation
sentences and the equally sized random collection of
mutation mentioning sentences. The scores of natural var-
iant mutation sentences (mean of 1.37) were significantly
higher when compared to the random subset (mean of
0.09), indicating that the overall scoring of natural variant
mutation mentioning sentences derived from the inde-
pendent SwissProt annotations are consistently higher
than a random subset.
For practical purposes it is often useful to determine the
actual performance of a system for a discrete set of score
intervals or cut-offs, to enable a more efficient selection of
instances for further examination or manual curation.
Therefore we selected random subsets for sentence score
intervals ranking from above 4 (positive class, natural var-
iant relevant) to minus 4 (negative class, induced muta-
tion or mutagenesis). Sentences of each of these sets
underwent a two-step blindfold manual classification
process to provide a more fine-grained analysis of the dif-
ferent aspects that might influence the actual systems per-
formance. The first step consisted in classifying whether
the sentence is mentioning a mutation or not to deter-
mine the effect of false positive mutation extraction. As a
separate class we also recorded cases of mutation men-
tioning sentences where the directionality of the automat-
ically extracted mutation event (wild type residue vs.
mutant residue) was wrongly derived. When considering
the mutation extraction performance across the score
intervals for mutations classified as induced and natural
variants, it seems that it was more difficult to correctly
identify mutation mentions in abstracts that where close
to the classification boundary or where scored as experi-
mentally generated mutations.
The second step involved manually classifying mutation
mentions into one of the following categories: (1) natural
variant, (2) induced mutation or (3) unclear cases. We
decided to add the latter category to take into account
mutation mentions that even by humans could not be
classified clearly into one of the two other types, either
because the context of mention is not informative enough
or because it is a truly ambiguous case. Figure 4E and 4F
provide a detailed overview of the results obtained from
this multi-step manual mutation classification for each of
the score intervals. The classifier results are identical to
human classification in over 95% of the cases for very
high and very low mutation sentences score intervals, but
drop to less than 77% for cases where mutations where
classified as natural variants with classifier scores close to
the classifier decision boundary (score interval of 1 to 0).
Finally we also selected randomly a larger set of mutation
mentions and carried out a bind fold manual labeling of
these cases, to analyze the overall performance of the
mutation classifier as well as to determine the distribution
of natural variant and induced mutation mentions from
PubMed abstracts. From the initially extracted set of muta-
tions, 93.9% corresponded to correct mutation mentions
without applying the mutation filter, compared to 97.0%Page 5 of 20
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Out of the correctly extracted mutations, 49.75% were
manually classified as natural variant mutations, very
close to the 47.2% of mutations classified as induced
mutations. Surprisingly only 3.05% corresponded to
unclear mutation types. Evaluating the sentence classifier
results against the manually classified labels resulted in a
precision of 93.88%, a recall of 91.09% (balanced f-score
of 92.46) and an accuracy of 93.88, in line with the per-
formance obtained with the previously used test set. An
interesting false negative case was the sentence: The hexa-
meric structure is important for protein stability, as dem-
onstrated by studies with natural mutants (the Killer-of-
prune mutant of Drosophila NDP kinase and the S120G
mutant of the human NDP kinase A in neuroblastomas)
and with mutants obtained by site-directed mutagenesis.
In this particular case the authors refer to both natural var-
iants as well as induced mutations, being S120G actually
a natural mutation.
Linking mutation mentions to human kinase sequences
Providing associations of mutations to their correspond-
ing protein record and sequence is crucial to facilitate a
more detailed characterization of structural effects of a
given mutation and distribution within certain protein
domains. This also allows direct comparison to functional
annotations of proteins and mutations contained in man-
ually curated annotation databases as well as to large-scale
experimental results obtained by genotyping studies. Here
we focus on associating the extracted mutations specifi-
cally to human protein kinases.
To obtain links between mutation mentions and human
kinases we assumed that the corresponding protein
Flow chart of the presented literature mining approach for mutation extractionigure 1
Flow chart of the presented literature mining approach for mutation extraction. This flow chart provides an over-
view of the different processing steps to extract mutations relevant for human kinases. The main steps include the construction 
of a kinase relevant article collection, the detection of mutation mentions, the scoring of the type of mutation (induced/natural 
variant), the linking of mutations to the corresponding protein sequence and the comparison to existing databases.Page 6 of 20
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extracting all the mutation mentions from PubMed
abstracts and a large collection of full text articles, these
two data sets were processed for retrieving mentions of
human protein kinases. In order to detect kinase protein
mentions we applied a dictionary look-up approach, sim-
ilar to strategies that participated successfully at the gene
normalization task of BioCreative II [35]. To take into
account inter- and intra-species protein name ambiguity,
rather than using very strict protein-organism source co-
mention criteria based on relative textual distances, we
calculated for each article two scores reflecting (1) the
contextual similarity of the article to the SwissProt protein
record and (2) the overall association of the article to
human species terms from the total set of tagged species
terms.
This high recall protein normalization scoring strategy
was followed by a more stringent sequence validation
approach that allowed us to detect links of mutations and
proteins by checking whether the actual mutation men-
tion can be confirmed by looking them up at the protein
sequence position. We restricted our analysis specifically
to mutations occurring in the protein kinase domain, as
defined in Kinbase [1]. A total of 567 triplets (i.e. article-
mutation-protein associations) derived from abstracts
could be validated by checking whether the extracted wild
type residue was found at the mutated position in the pro-
tein sequence. In addition to this basic sequence look-up
validation method we implemented five complementary
mutation-sequence mapping strategies that take into
account both, errors resulting from the wrong detection of
the actual directionality of the extracted mutation with
respect to wild type and mutant residues as well as incon-
sistencies and alternative sequence counting between the
article and the database kinase sequence (see methods
section). By applying this additional matching strategies
we were able to recover 437 additional hits, correspond-
ing to 43.53 percent of the total set of sequences validated
protein mutation pairs. This resulted in a total of 1,004 tri-
plets from 714 abstracts. In case of full text articles, the
total number of triplets detected by the basic mapping was
3,911, being another 3,917 triplets recovered through
additional sequence mapping methods. This resulted in
7,828 triplets from 3,496 full text articles. The average
number of sequence validated mutations in the Protein
Mutation type frequencies from PubMed and SwissProtFigure 2
Mutation type frequencies from PubMed and SwissProt. A. Relative frequency of each mutation type derived from 
PubMed abstracts and from the SwissProt database. B. Most frequent mutation types from PubMed abstracts, and from Swiss-
Prot (SP), annotated as natural variant or induced (mutagenesis) substitutions. C. Values of the Spearman rank correlation 
between the text mining derived mutation types and the database derived mutation types. All p-values are below 10e-6, there-
fore statistically significant.Page 7 of 20
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cles 2.24, implying that often more than a single mutation
is described in a given paper.
The global context of co-mention of kinase proteins and
mutations defined by the multi-document collection
where these co-occur, can be indicative for the actual
importance of a particular mutation, being described and
studied in various different paper. To use information
provided by the corpus co-mention context, in addition to
the total number of documents where the sequence vali-
dated mutation-kinase pair co-occurred we calculated the
mutual information for each mutation pair.
Comparison of text mining mutations to databases and 
genotyping studies
Several genomic studies (including a comprehensive anal-
ysis of all human kinases) have been dedicated to the
characterization of mutations occurring in protein kinases
in a variety of cancer tissues and cell lines. In these studies,
a number of point mutations detected in somatic cell lines
have been found to be associated with specific cancer
types. The pathogenicity of these mutations depends on
multiple factors related to the complex molecular envi-
ronment in which protein kinase function takes place. Of
special interest are mutations found within the protein
kinase domain, as it is essential for the functional activity
of these proteins. We therefore focused our analysis on
automatic extraction of mutations mapped to this partic-
ular domain, common to all kinases, and carefully exam-
ined how they relate to previously characterized
mutations retrieved from multiple databases and experi-
mental high throughput genomic studies. We used the
kinase domain definition followed by Kinbase [1], ana-
lyzing both the distribution of mutations within the Pro-
tein Kinase Domain, as well as the distribution of
mutations according to the corresponding protein family
topology. A total of 643 kinase domain sequence muta-
tions were extracted from PubMed abstracts for a total of
128 different proteins. When considering the full text col-
lection, we were able to increase considerable this
number, obtaining a total of 6,970 mutation-protein pairs
from 325 proteins. Using full text articles resulted there-
fore in a considerable increase of recovered mutations
(more than 10 times more mutation-protein pairs when
compared to abstracts) as well as being useful to increase
the recall of proteins for which mutations had been
extracted (more than doubling the initial number derived
form abstracts alone). The increased recall for full text
papers clearly justifies the computational effort required
to retrieve and preprocess them.
Figure 5A shows the distribution of the mutations
extracted from the literature into the different groups in
which Kinbase [1] classifies the protein kinase domain of
the human kinases. For a more detailed description of the
different kinase groups refer to the methods section.
Although there are differences in the number of muta-
tions present – with more than a half of the mutations
either within the TK or the CMGC clades – all the main
groups are represented in the results both when PubMed
abstracts or full text articles are taken into consideration.
Figure 5B depicts the normalized distribution of muta-
tions in the different protein kinase domain groups in
which Kinbase classifies the human kinome when the
abstracts and the full text articles are taken into account
respectively. It is evident that no matter which dataset is
used, either abstracts or full-text articles, the distributions
are very similar independently of the very uneven abso-
lute numbers between both datasets, which confirms that
complementary results are provided by the two very dif-
ferent approaches.
Comparative analysis of wild type residues and mutations extracted from Swis Prot and using text miningFigure 3
Comparative analysis of wild type residues and muta-
tions extracted from SwissProt and using text min-
ing. This chart illustrates differences in terms of wild type 
and mutant residue frequencies derived from the SwissProt 
database and obtained through automatic literature process-
ing. A. Relative frequency of each wild type residue derived 
from mutations extracted from PubMed abstracts and from 
the SwissProt database. B. Relative frequency of each mutant 
residue derived from mutations extracted from PubMed 
abstracts and from the SwissProt database.Page 8 of 20
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In order to assess whether the mutations recovered from
the existing literature by our system were already present
in commonly used databases or are newly recovered
instances, we herein studied the overlap between the
mutations in the protein kinase domain both in the data-
bases and the results from our extraction pipeline. Table 2
represents the percentage of each database covered by the
Text Mining results.
Recovery of disease associated mutations: overlap with KinMutBase
KinMutBase [8] is a manually curated knowledge base for
human disease-related mutations in protein kinase
domains. At the time of the study, March 2009, a total of
83 single-point pathogenic mutations in the protein
kinase domain of 10 different proteins were provided in
KinMutBase. We were able to confirm 32 (38.55%) of
these mutations from abstracts and also the same number
 from full text articles. When combining the mutations
from both article collections we recover more than half of
the mutations from KinMutBase, namely a total of 43
mutations (51.81%). This suggests that the mutation
mentions from both document collections are essentially
complementary, and some of them could only be detected
in one of the document sets.
Recovery of natural variant and induced mutations: overlap with 
SwissProt database
The Swissprot Variant database [31] provides experimen-
tally-verified information about mutations present in
UniProtKB, containing a set of 710 mutations in the pro-
tein kinase domain of 194 different proteins. 251
(35.35%) of them corresponding to mutagenesis experi-
ments whereas 459 (64.65%) correspond to reported nat-
ural sequence variants. Using our text mining approach
we were able to recover 134 (18.87%), 328 (46.20%) and
365 (51.41%) of the mutation contained in the database
when the abstracts, the full texts and the combination of
both was used, respectively.
When considering the overlap of extracted mutations with
respect to each of these two mutation type classes (natural
variants and mutagenesis) we were able to obtain similar
percentages for both groups from the combined article
collection, 50.11% of the mutations annotated as natural
variant and 53.78% of the mutations annotated in Swiss-
Prot as mutagenesis.
Interestingly, we found differences in the overlap percent-
ages of recovered mutations from abstracts and from full
text articles when looking at these mutation classes indi-
vidually. When considering the mutations derived from
abstracts, 21.57% of the natural variant annotated muta-
tions could be detected, as opposed to only 13.94% of the
mutagenesis annotated mutations. The opposite trend
was observed in case of full text articles, where we
extracted 52.59% of the induced mutations and 42.70%
of the natural variant mutations. This suggests to certain
extent that experimentally induced mutations annotated
in SwissProt are usually not mentioned in abstracts, but
rather in full text articles.
Recovery of structurally important mutations: overlap with the 
SAAPdb repository
The SAAPdb [33] is a resource for the analysis and visual-
ization of the structural effects of mutations. At the time
of this study, SAAPdb contained 610 point mutations
located in the protein kinase domain of 230 proteins.
52.95% (323) of the information corresponds to muta-
tions previously reported as pathogenic deviations (PDs)
whereas the rest corresponds to neutral SNPs (287,
47.05%).
Our system recovered 65 (10.66%) and 106 (17.38%) of
the mutations previously stored in the database when the
abstracts and full text articles were taken into considera-
tion. For the joint abstracts-fulltext dataset, 125 (20.49%)
of the mutations present in SAAPdb were found.
With regard to the pathogenicity of the mutations found,
for the particular case of the combined dataset, we were
able to find 123 (38.08%) of the pathogenic deviations,
whereas only 2 neutral SNPs were recovered. This high-
lights the fact that the literature is biased towards those
mutations known to be functionally active and harmful
for the individual. It is interesting to remark that none of
the other databases analyzed contained records for the
neutral SNPs in SAAPdb either.
Recovery of somatic mutations: overlap with the Greenman and 
Wood dataset
The Greenman and Wood dataset was built from the
results shown in the original papers [14,16] by the
authors where they report 254 somatic mutations corre-
sponding to the protein kinase domain of 164 proteins in
diverse human cancers. In addition, the mutations are
sub-classified according to the pathogenic character pre-
dicted into drivers (cancer associated somatic mutations)
and passengers (neutral mutations). The contribution of
each class to the whole database is 46.85% and 53.15%
respectively.
Our system recovers only a very small fraction of these
somatic mutations since only 13 (5.12%) of the instances
in the dataset were able to be recovered in the best case
scenario, where the combined article set (abstracts+full-
text) was used. This means that only a small proportion of
the mutation dataset detected by experimental High
Throughput approaches could be linked directly to otherPage 9 of 20
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driver mutations versus 4 (2.96%) passenger mutations. A
very similar trend was observed for the case of the COS-
MIC database, which shares around 95% of the informa-
tion contained in the Greenman/Wood dataset for the
particular case of the protein kinase domain.
Result summary and structural mutation distribution
Finally, we wanted to assess how many of the mutations
we were able to recover from the total set of mutations in
the 5 studied datasets (namely, SwissProt database [31] as
well as the COSMIC [32], Greenman/Wood dataset of
somatic mutations [14,16], KinMutBase [8], and SAAPdb
databases [33]) in order to get a view of the coverage of
the existing knowledge by our method. To do so we built
a non-redundant set with 1265 mutations in 317 different
Evaluation of classifying induced mutation mentions and natural variantsFig re 4
Evaluation of classifying induced mutation mentions and natural variants. A. Box plot of the sentence classifier 
scores for Natural Variant (NV) annotated mutations in SwissProt and a random subset of sentence scores from mutation 
mentioning sentences. B. Example cases of mutation mentions corresponding to natural variant and induced mutations. C. 
Example features used by the sentence classifier for the positive class (Natural Variant) and the Negative class (Figure D, 
induced mutation). E and F Manual classification result for 50 randomly selected mutation mentioning sentences for classifier 
score intervals. (1) Score above 4, (2) score range of 4-3, (3) score range 3-2, (4) score range 2-1, (5) score range 1-0, (6) 
score range 0 to minus 1, (7) score range from minus 1 to minus 2, (8) score range from minus 2 to minus 3, (9) score range 
below minus 3. Positive scores correspond to mutations classified as natural variant, negative scores correspond to mutations 
classified as induced/mutagenesis.Page 10 of 20
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Distribution of literature extracted mutations in the groups defined by KinbaseFigure 5
Distribution of literature extracted mutations in the groups defined by Kinbase. A. Number of mutations from the 
literature lodging in the different protein kinase domain groups in which Kinbase classifies the human kinome when the 
abstracts and the full text articles are taken into account respectively. B. Normalized distribution of mutations in the different 
protein kinase domain groups in which Kinbase classifies the human kinome when the abstracts and the full text articles are 
taken into account respectively
BMC Bioinformatics 2009, 10(Suppl 8):S1 http://www.biomedcentral.com/1471-2105/10/S8/S1kinases. The different databases are unevenly represented,
and the weight of each database is reported in the last row
of Table 2, where the overlap between the different data-
bases is assessed, under the epigraph 'All Databases'.
Out of the 1265 mutations in the combined database, 148
(11.70%) were found by the Text Mining approach when
the Pubmed abstracts were scanned. By contrast 354
(27.98%) mutations were recovered when the full-text
articles were taken into consideration, and 399 (31.54%)
when the combined abstracts+fulltext dataset was used.
The increased recall of this combined method clearly jus-
tifies the computational effort required.
Although there are mutations scattered everywhere in the
kinase domain structure, a considerable mutation density
is encountered close to functionally relevant parts of the
protein, i.e. the ATP binding pocket, the DFG motif in the
activation loop. Figure 6 shows a detailed view of the
mutation density distribution within the protein kinase
domain model. ATP binding Lysine 64 shows the highest
density of mutations, with a total of 65 mutations, fol-
lowed by residues forming the activation segment (up to
39 mutation per residue) and several residues conforming
the ATP binding pocket.
Worked example: the Epidermal Growth Factor Receptor
The interest of the system presented here is not only that
the user can gather mutations from the literature that are
not reported in the databases, but also that one can get a
summary of sentences mentioning those mutations that
will help to assess the pathogenicity (and in the best pos-
sible scenario, the function) of the mutations newly dis-
covered. A working example is provided here: Mutations
in the EGFR.
The epidermal growth factor receptor, also known as
EGFR, is a protein kinase involved in the control of cell
growth and differentiation which has been reported of
interest in the development of breast cancer since binding
of EGF to its receptor leads to dimerization, internaliza-
tion of the binary complex, induction of the tyrosine
kinase activity, stimulation of cell DNA synthesis, and cell
proliferation.
There are several well-known mutations reported for this
protein in current state-of-the-art databases storing infor-
mation on mutations (SwissProt [31], COSMIC [32],
Greenman/Wood [14,16], KinMutBase [8], SAAPdb [33])
Even more, for some of them, their involvement in disease
has been investigated and annotated in the corresponding
databases. For instance, the somatic mutations G719S,
L858R and T790M have been previously reported in rela-
tionship with lung cancer [16,36].
By contrast, our system was able to recall from the litera-
ture 32 mutation mentions that have not been reported in
the dedicated databases. In order to better understand the
effect of these mutations, our approach is also capable to
provide context information that can be used for the inter-
pretation of the role played by the mutations as described
herein.
To provide an example, in the case of Y845F (transformed
to Y869F due to the presence of a signal peptide) we were
able to find the following sentences 'Furthermore, tran-
sient expression of a Y845F variant EGFR in murine
fibroblasts resulted in an ablation of EGF-induced DNA
synthesis to nonstimulated levels.' (PMID:10075741),
'Stably transfected B82L cells with a point mutation of the
EGFR at Tyr-845 (B82L-Y845F) exhibited only basal Ras
activity following exposure to Zn2+' (PMID:11983694),
'In contrast, LPA-elicited DNA synthesis and migration
were augmented in cells expressing EGFR, EGFR(K721A),
or EGFR(Y845F), but not EGFR(Y5F), although the PDGF
responses were indistinguishable' (PUBMED 15364923).
The information retrieved suggests the involvement of
Tyrosine-845 from EGFR in DNA synthesis via binding to
EGF.
In addition, the system also retrieves functionally neutral
results that are often discarded and not stored in the data-
bases although they contain very useful information for
the contextual interpretation of the involvement of point
residues in protein function 'Unexpectedly, the Y845F
mutant EGFR was found to retain its full kinase activity
and its ability to activate the adapter protein SHC and
extracellular signal-regulated kinase ERK2 in response to
EGF, demonstrating that the mitogenic pathway involving
phosphorylation of Y845 is independent of ERK2-activa-
tion' (PUBMED 9990038). The structural model of this
protein together with a summary of the residue and muta-
tion information is included in additional material file 3
Conclusion
In this paper we presented the first approach to extract
human kinase mutations from both PubMed abstracts
and a large collection of full text articles, comparing the
obtained results to mutations that have been manually
curated from the literature by annotation databases as
well as data generated by genotyping studies. Automated
mutation extraction can assist manual curation efforts by
providing direct pointers to mutation evidence sentences
for quick manual examination. The MutationFinder sys-
tem was useful to detect mutation mentions from both
abstracts and full text articles combined with some addi-
tional filtering of ambiguous mutation mentions. Some
potential future improvements of this basic mutation
extraction system could consider wrongly extracted muta-
tion mentions resulting from mentions of sequencePage 12 of 20
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R97X). Several strategies have been used to filter ambigu-
ous mutation mentions and to discriminate between
mutations at the level of DNA and proteins. We carried
out a detailed consistency analysis of the mutations
detected by means of literature mining to the content of
manually curated annotations. Future steps could include
a more detailed exploration of the actual reliability scor-
ing and ranking of sequence validated mutations through
the use of: (1) mutation-protein proximity analysis in full
text articles, (2) species and organism source ambiguity
examination and (3) analysis of the probability of finding
a given mutation within the target sequence per chance,
considering the actual residue composition of proteins
and kinases. By using a standard machine learning
approach we were able to score the level of phenotypic
description based on contextual information provided for
a given mutation, classifying each mutation mention as
induced (artificial, generated by mutagenesis experi-
ments) or natural variant (polymorphisms, SNPs and
somatic mutations). This aspect is especially important as
it connects mutation relevant information generated by
different scientific domains, i.e. data generated by clinical,
epidemiological and human genetics studies with molec-
ular biology and biochemical in vitro experiments. Extrac-
tion of mutation information from multi-document
collections is useful to complement different scientific dis-
coveries and characterizations described across various
papers, increasing thus efficiency in relating entries to
each other and integrating multiple complementary evi-
dences discovered by different research groups. Problems
related to sequence shifts or cases of so-called sequence
conflicts when comparing the numbering used by article
authors to the sequences contained databases like Swiss-
Prot were addressed by using various sequence validation
strategies, from the basic residue look-up to the use of text
derived sequence patterns. These Sequence conflicts can
be the result of sequencing errors, sequence variants or
isoforms that are not well characterized or even from
alternative counting when considering N-terminal signal
peptides [28]. To resolve such sequence conflicts is even a
cumbersome task for human experts. We can recover
7,184 potential mutations on kinases in the Protein
Kinase Domain from text (643 from abstracts and 6970
from full text). Information from abstracts and full text is
essentially complementary, as sometimes the full text arti-
cle for a mutation mentioning abstract is not available or
even written in another language different from English.
Although some of the extracted mutation-kinase associa-
tions might be erroneous, they still provide a very good
basis for additional annotation efforts, in some cases val-
uable for the in depth analysis of specific proteins (as in
the example shown here).
Interestingly only a very minor fraction of the mutations
detected in hight throughput genotyping studies [14,16]
correspond to previously identified mutations mentioned
in the literature. As a considerable number of these HT
generated data correspond to mutations that do not have
any deleterious effect, it is understandable that they lack
further careful characterization published in the literature.
In general we find that 31.54% of the mutations con-
tained in manually annotated databases can be directly
recovered from papers, important for assuring the data-
base-literature coherence. The remaining mutation
records lack direct evidence about its origin in text, poten-
tially due to (1) missing accessibility of the corresponding
full text articles or additional materials (especially in case
of older publications), (2) general limitations in terms of
recall of mutation mention extraction methods or (3) lim-
itations in the protein normalization and mutation to
sequence associations. We estimate that, based on the
proportion of natural and artificial variations described in
the literature, a considerable fraction of the text mining
derived mutations not contained in any of the existing
kinase mutation resources might correspond to experi-
mentally generated induced mutations. From a manual
inspection of natural variant mutations we were able to
differentiate between four main mutation types, some of
them not considered as annotation relevant by existing
databases but nevertheless important for interpreting the
practical relevance of individual mutations, these include:
(1) mutations with no clear association to the studied dis-
ease phenotypes, (2) mutations that are protective against
some pathological condition, (3) mutations that are dele-
terious and that promote the pathological condition (e.g.
increased disease risk). On the symmetric view 5.55% of
the automatic literature annotations (23.02% from
abstracts and 5.08% from full text) correspond to data-
base confirmed entries, implying that a considerable frac-
tion of the extracted mutations through literature mining
is potential new information still to be annotated. In
order to assess to which extent this new information can
be trusted a human expert manual validation protocol
was conducted on a randomly selected sample of 100
mutations taken from mutation mentioning abstracts (see
Figure 7). We demonstrate in this work how the power of
text mining combined with bioinformatics approaches
can be used to discover and link information in key areas
of biology, being able to result in a framework for sup-
porting manual mutation literature curation and with the
potential to adapt an analogous pipeline to other protein
families going beyond the kinase/mutation analysis. Our
work resulted in a collection of kinase mutation literature
links (mutations, positions, sentences) derived form both
full text articles and abstracts. Our work shows that extrac-
tion of mutations from full text articles is feasible and that
it could be applied to the whole set of full text articlesPage 13 of 20
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vide din the future.
The experiment shows that for 23% of the mutations there
was a positive confirmed record in at least one of the ana-
lyzed knowledgebases (SwissProt [31], COSMIC [32],
Greenman/Wood [14,16], KinMutBase [8], SAAPdb [33]),
being consistent with the results previously shown for the
automatic extraction pipeline. In addition, and an impor-
tant added value provided by our system, 41% of the
results were correct assignments between the protein and
the mutation extracted by text-mining that were not
reported in the knowledgebases. Finally, 8% of the muta-
tions corresponded to orthologs having the same amino
acid that the human protein at the specified position,
which can be considered positive hits as well, as they
essentially represent information generated for human
kinases using animal models. In summary, we estimate
that almost three quarters (72%) of the extracted muta-
tions correspond to positive hits being either previously
annotated mutations, correct novel mutations or muta-
tions of close orthologs.
Interestingly, a small proportion of the records (2%) were
too ambiguous even for human experts, lacking enough
information even to perform manual validation.
Materials and methods
Sequences of protein kinase domains using KinBase
The KinBase resource (http://www.kinase.com/kinbase,
[1]) is a repository storing the currently accepted classifi-
cation of eukaryotic protein kinases, which are catego-
rized into two main groups: 'conventional' protein
kinases (ePKs) and 'atypical' protein kinases (aPKs). The
ePKs form the largest group and they have been subdi-
vided into eight groups by sequence similarity of the cata-
lytic domains, the presence of accessory domains, and by
considering different modes of regulation. The eight ePK
groups defined in KinBase are: the AGC group (including
cyclic-nucleotide and calcium-phospholipid-dependent
kinases, ribosomal S6-phosphorylating kinases, G pro-
tein-coupled kinases and close relatives of these kinases),
the CAMKs (calmodulin-regulated kinases); the CK1
group (casein kinase 1 and close relatives); the CMGC
group (including cyclin-dependent kinases, mitogen-acti-
vated protein kinases, CDK-like kinases and glycogen syn-
thase kinase); the RGC group (receptor gyanylate cyclase
kinases); the STE group (MAP Kinase cascade kinases),
Tyrosine kinase group (TKs); and the TKL group (Tyrosine
kinase like family) which are a cluster of serine-threonine
kinases resembling TKs. Another broad, miscellaneous
group called 'other' is also considered for those proteins
that do not fit in any of the predefined sets.
At the time of the analysis, KinBase contained 620 human
protein sequences of which 518 correspond to protein
kinases not considered to be pseudogenes. Although
kinases described as pseudogenes are transcribed and
might even have a residual or scaffolding function, kinase
pseudogenes were not mapped onto Uniprot (SwissProt/
Trembl) since many of them are partial transcripts or have
stop codons in their sequence. Since KinBase does not
directly map its entries onto Uniprot, this mapping was
performed using a BlastP [37] search for each kinbase
sequence against a custom database containing all entries
in Uniprot annotated as human protein kinase domain.
Once the mapping was performed, we were able to map
488 Kinbase identifiers to a valid Uniprot entry, 474 of
them (97.13%) at sequence identity levels of at least 95%.
Mutation extraction from abstracts and full text articles
The used mutation extraction pipeline has been applied to
two text data sets, one consisting in the whole collection
of PubMed abstracts, and the other in a set of 19,404 full
text articles. The full text articles were automatically
downloaded using an in house full text retrieval system
that had previously been implemented. To prioritize full
text articles for download, three different criteria were
considered. The first selection criteria was based on infor-
mation contained in the corresponding abstracts, such as
mention of mutations, mention of human kinase proteins
and a combination of keywords (including 'human kinase
mutation'). The second selection criteria was based on
extracting all the PubMed references for human kinases
contained in multiple databases (e.g. SwissProt, MINT,
IntAct). The third selection criteria was based on analyz-
ing the fraction of mutation mentioning abstracts for each
journal, prioritizing a set of journals (and thus their arti-
cles) for retrieving their full text articles. These journals
included: the American Journal of Human Genetics, Euro-
pean Journal of Human Genetics, Human Genetics,
Human Mutation and Human Molecular Genetics. Each
of the full text articles was automatically converted into
plain text using pdftotext. Both abstracts and full text arti-
cles were then preprocessed applying an in house rule-
based sentence boundary detection system that we opti-
mized for PubMed abstracts. We applied the Mutation-
Finder system two both the full text and abstract sentence
collections using a cluster of 64 Mac PPC G5 processors
running Darwin.
Mutation disambiguation and filtering
The performance of information extraction methods that
detect mutation mentions from the literature is affected
by the underlying article selection criteria used. When
applied to the whole PubMed database, a fraction of
extracted mutation mentions are ambiguous, and there-
fore can, depending on the context correspond to a range
of other bio-entities, like cell lines, protein names orPage 14 of 20
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more careful examination of wrongly extracted mutation
mentions, most of these ambiguous mentions correspond
to single letter mutations. Horn et al. compiled manually
a list of exceptions to avoid mislabeling of other phrases
as mutations, examining also certain terms co-mentioned
in the context (e.g. cell line, tumour or cancer). For filter-
ing single letter mentions that might correspond to muta-
tions at the level of DNA or RNA they analyzed words
surrounding the point mutation, but did not provide fur-
ther details regarding this process [27]. Erdogmus and col-
leagues addressed DNA versus protein mutation
disambiguation through a supervised learning approach
based on the Naïve Bayes algorithm, they prepared a col-
lection of 2,771 mutation mentions at the protein level
and 768 at the DNA level and obtaining an accuracy of
84.7 [24].
We propose an approach for targeted mutation pattern
sense disambiguation and filtering of mentions that do
not correspond to protein mutations. Therefore we exam-
ined manually a large collection of mutation mentions to
determine the sense inventory with respect to the context
of occurrence, discriminating the main classes of false
positive ambiguous mutation mentions and characteriz-
ing their semantic categories. The majority of these corre-
sponded to one of the following three semantic types:
• Cell lines or cell types. There are several frequently
mentioned cell lines that resemble mutation men-
tions. Among these are the human glioblastoma cell
line T98G, the T-cell line M14T, the adrenocortical cell
line H295R or other commonly used cell lines such as
T47D or T24C.
• Taxonomic entities. Certain taxonomic names, espe-
cially bacterial strains, cloning vectors and certain ani-
mal models (e.g. mouse strains) contain words that
are similar to single letter mutations. Example cases
include the strains: E. coli K12S, A. viscosus T14V, P.
pneumoniae R36A, A. naeslundii T14V, Mycoplasma
sp. G145T or the yeast strain S288C. Also clone iden-
tifiers (e.g. W12I and W12E) or plasmids (e.g. E. coli
plasmids P15A) can result in false positive mutation
hits. A special case of ambiguous mutation mentions
is encountered in transgenic mouse models like G93A
transgenic mice. It consists in a mouse strain express-
ing a G93A mutant form of human SOD1 protein, but
usually is mentioned as the name of the strain rather
than as a reference to this particular mutation.
• Protein and gene names. Several protein names do
match the patterns used to identify mutations from
the literature, although some of these correspond to
human proteins like S100D and S100E, a considerable
fraction are viral gene names (e.g. A10L of the vaccinia
virus, A11L variola virus or the poxvirus protein
A52R).
We found some additional cases of wrongly tagged muta-
tions that could be classified as drugs or compounds (e.g.
the antibiotic A83586C, the immunogen A27L or the anti-
fungal antibiotics A9145C). To determine the semantic
class of a given mutation occurrence we explored the use
Table 2: Overlap between the different knowledgebases and the literature extracted mutations
Literature derived mutations and overlap with knowledgebases
Knowledgebase (KB) Total Mutations in KB 
[weight]
Abstract Full Text Combined (Abs+FT)
SwissProt – all 710 [56.13%] 134 (18.87%) 328 (46.20%) 365 (51.41%)
SwissProt – natural 
variant
459 [36.28%] 99 (21.57%) 196 (42.70%) 230 (50.11%)
SwissProt – 
mutagenesis
251 [19.84%] 35 (13.94%) 132 (52.59%) 135 (53.78%)
SAAPdb – all 610 [48.22%] 65 (10.66%) 106 (17.38%) 125 (20.49%)
SAAPdb – pathogenic 
deviations
323 [25.53%] 64 (19.81%) 105 (32.51%) 123 (38.08%)
SAAPdb – neutral 287 [22.69%] 1 (0.35%) 1 (0.35%) 2 (0.70%)
Greenman & Wood 254 [20.08%] 4 (1.57%) 12 (4.72%) 13 (5.12%)
Greenman & Wood – 
driver
119 [9.04%] 3 (2.52%) 9 (7.56%) 9 (7.56%)
Greenman & Wood – 
passenger
135 [10.67%] 1 (0.74%) 3 (2.22%) 4 (2.96%)
COSMIC 200 [15.81%] 4 (2.00%) 11 (5.50%) 12 (6.00%)
KinMutBase 83 [6.56%] 32 (38.55%) 32 (38.55%) 43 (51.81%)
All Databases 1265 148 (11.70%) 354 (27.98%) 399 (31.54%)Page 15 of 20
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ble dictionaries (MRDs) for sense disambiguation based
on local context analysis. In order to address this disam-
biguation task we assumed (1) One sense per discourse,
namely that within a given document the target mutation
mention is consistently used as either a mutation or one
of the three other semantic types previously introduced;
and (2) One sense per collocation, implying that nearby
co-mentioned words provide strong clues to the sense of
the target mutation mention.
Three lexical resources were compiled for taxonomic enti-
ties, protein/gene names as well as cell lines. Due to lim-
ited lexical coverage of cell line information in existing
biological ontologies such as the Cell Type ontology, we
generated automatically a cell line dictionary through use
of a named entity recognition method (ABNER, [28])
applied to mutation mentioning PubMed abstracts. This
resulted in a total of 9,252 cell line names, out of which
1,124 corresponded to mentions that could potentially
match mutation patterns. We incorporated from the list of
cancer cell lines contained in the COSMIC database five
additional names resembling mutations. This cell line dic-
tionary was used to filter ambiguous mutation mentions
(over 13,500 sentences). We also generated automatically
922 pattern templates based on multi-word cell line
names, where the original word resembling a mutations is
used as a slot to be filled with ambiguous mutation men-
tions (see table 3).
For taxonomic entities we assembled a dictionary of spe-
cies names derived from the NCBI Taxonomy and used a
dictionary look-up approach with these names for filter-
ing potentially ambiguous mutations. A total of 584 taxo-
nomic names (and their variations) contained words
matching mutation regular expressions, most of them
from cloning vectors and bacterial strains. Out of these we
generated 128 disambiguation patterns for taxonomic
mentions. A similar approach was followed for disam-
biguation of mutations matching protein and gene
names, relying on a protein dictionary extracted from the
UniProt database. The total number of protein and gene
names from UniProt matching mutation mentions was
295. These were exploited for generating 29 disambigua-
tion patterns that were manually revised to remove too
general patterns, resulting finally in a set of 25 patterns.
A special case of ambiguity is encountered when distin-
guishing between mutations at the level of DNA, RNA and
protein sequences. To enable discrimination between
these different mutation types official nomenclature
guidelines state that the description should be preceded
by a letter indicating the type of reference sequence, p in
case of protein sequences (e.g. pCys76Ala or p.C76A), g
for genomic sequences, c for cDNA, m for mitochondrial
sequences and r for RNA sequences [38]. Unfortunately in
practice these standards are not sufficiently followed
resulting commonly in ambiguity at the level of the corre-
sponding reference sequence type, which requires a spe-
cific disambiguation strategy. This scenario is somehow
similar to the distinction between gene and protein men-
tions, where even for human experts it is sometimes chal-
lenging to make clear decisions.
To handle the automatic distinction between DNA and
protein mutations, we explored the use of different selec-
tion criteria that humans actually follow to achieve this
task. We applied a hand crafted rule-based technique,
with the implicit advantage that it does not require the
construction of large training collections of representative
sample cases for different types of DNA/protein ambigu-
ous mutations. As contextual representation for disam-
biguation of mutation patterns we used: (a) implicit
information from the mutation itself, i.e. mutation
sequence position, (b) features derived from the local
context, i.e. words enclosed in the corresponding sen-
tence, and (c) distant content words from the whole
abstract as contextual cues, i.e. other co-occurring muta-
tions.
A useful characteristic to distinguish mutations at the
DNA and protein level is actually provided by the muta-
tion position number. The average length of sequences in
UniProt is 360 amino acids, being the longest sequence
35,213 (the Titin protein from mouse). When looking at
the mutation positions annotated in SwisProt, 96.76% are
below 2000, 98.72% are below 3000 and 99.25% are
below 4000. Therefore a basic aspect that we explored
here was to filter mutations by position numbers allowing
three positional cut-offs (2000, 3000 and 4000). Example
cases of DNA mutations that can be successfully detected
with this simple criterion are T1191C (PMID 15993850),
G2950692A (PMID 15862761) and G20210A (PMID
18501222).
The local context of a given mutation mention, repre-
sented by the sentence in which it occurs can provide
hints towards the mutation type. We generated two lists of
terms that are associated either to mutations at the level of
proteins or DNA based on manual inspection and exten-
sion of the features used by a sentence classifier trained on
a small sample set of 687 DNA and protein mutation
mentions. We used terms from these two lists mentioned
within the mutation sentences to calculated the overlap
coefficient of Lesk for scoring them as DNA or protein
associated [39].
Certain distant content words co-occurring with a muta-
tion in the whole abstract can be used as contextual cues
for disambiguation. Here we explored the use of other co-Page 16 of 20
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for mutation disambiguation, under the assumption that
if multiple mutation patterns co-occur, and all of them
resemble DNA mutations, it is consequently more proba-
ble for each of them to corresponds to a DNA rather than
a protein level mutation. From manual examination of
the resulting hits, we determined that at least 4 distinct
mutations had to be co-mentioned in a given abstract, and
that at least two different mutation combinations were
needed (to avoid filtering of systematic Cys to Ala-scan-
ning mutations). An example case illustrating this idea is
the PubMed record 9240741, where all the following
mutations are co-occurring: T1448C, T1366G, G1604A,
A1226G. Finally we also took into account the numerical
relation underlying the codon triplets and their encoding
for amino acids as filtering criterion for cases where for a
given ambiguous mutation, another co-mentioned muta-
tion fulfill the positional information condition: position
of DNA ambiguous mutation is equal to 3 times the posi-
tion of a co mentioned mutation, as illustrated for C684G
and N228K in: The novel mutations include T302C
(L101P), C684G (N228K), and G1063C (A354P) (PMID
9889017).
Mutation phenotype level classification: natural and 
induced
The classification of mutation mentions into natural vari-
ant or induced mutations was carried out using a sentence
classifier approach using words co-mentioned with the
mutation within the sentence. We used a SVM implemen-
tation (SVMLight, [40]) with radial basis kernel function
(default parameters) which explored several feature
weightings, finally using term frequency in order to avoid
inconsistencies resulting from the class balance when
weighting the used features. The initial feature dictionary
was filtered using an in house stop word list (See addi-
tional file 4). We carried out also additional word filtering
to remove numerical expressions and words with a length
below 3 characters. The training set of sentences was
Localization of the mutations extracted from the Pubmed abstracts within the structure of the Protein Kinase domainFigure 6
Localization of the mutations extracted from the 
Pubmed abstracts within the structure of the Protein 
Kinase domain. The ATP binding pocket is represented 
with sticks. The DFG motif (activation segment, essential for 
kinase function) allocates a big number of mutations. The 
light brown Asparagine (central part of the figure) in the 
inter-lobe region, more than 10 mutations. The highest den-
sity residue is Lysine 64 (red), allocating 65 mutations. This 
residue has been reported as essential for protein function 
and ATP binding. We observe that most of the mutations 
allocate in or near the ATP binding pocket or the activation 
segment and that mutations outside the binding pocket cor-
respond generally to low mutation density residues (colored 
in grey and green in the kinase domain model).
Success estimate of the extraction pipeline by human expert manual validationFigure 7
Success estimate of the extraction pipeline by human 
expert manual validation. These percentages were calcu-
lated upon a manual sampling and validation protocol con-
ducted on 100 abstracts. Correct – Database confirmed: 
These are the mutations that have been found already in at 
least one of the analyzed databases (Uniprot, SAAPdb, COS-
MIC, KinMutBase or Greenman). Correct-Manual validation: 
This subset corresponds to the mutation-protein pairs that 
have been found correct after manual validation on 100 
abstracts. Correct – Orthologue: This subset corresponds to 
the cases where mapping is confirmed by manual validation 
and the mutation is mapped to a non-human orthologue. 
Incorrect Mutation to Protein Assignment: Corresponds to 
the cases where both proteins share the same amino acid at 
the mutated position and the algorithm choses the incorrect 
pair. Incorrect Mutation assignment: Cases where the muta-
tion is not properly identified. An interesting particular case 
are the confusion with cell lines (accounting 66% of this cate-
gory) Too ambiguous even for human experts: Odd little 
informative cases where even human experts reading the 
abstracts are not able to identify to which protein the muta-
tion corresponds to.Page 17 of 20
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and then cross checked using the SwissProt database
whether they corresponded to natural variant or mutagen-
esis annotations.
Protein and species mention detection
For the detection of protein and organism names we used
a dictionary look-up and maximum sub-string matching
algorithm implemented in C and Perl. The initial gene
and protein dictionary of human kinases was extracted
from SwissProt and automatically extended using heuris-
tics and rules taking into account common typographical
variations encountered in gene and protein names and
symbols. These covered aspects related to the use of
hyphens (generating variants with hyphens, with white
space and without white space), capitalization (generat-
ing variants in upper case letters and capitalized versions)
and word ordering. This resulted in a human kinase pro-
tein dictionary of 2,582,220 protein name-database iden-
tifier associations. This dictionary was further manually
processed based on the information content of each
tagged protein mention to remove some highly ambigu-
ous protein name variations.
Mutation sequence validation
To associate co-mentioned proteins and mutations from a
given article, previous efforts [19,27] often considered
local text associations in terms of distances between a
mutation and the nearest mentioned protein (proximity
scores). These document-centric associations have clear
limitations in terms of the performance, and therefore
recent efforts tried to improve the underlying perform-
ance through looking up the mutation at its correspond-
ing position within the protein sequence. In an effort to
increase the recall of the method we implemented a cas-
cade of several strategies for mutation sequence validation
that included the following strategies: (1) Sliding window
algorithm that searches for a pattern of mutations along
the sequence instead of exact position – using the num-
bering given in the mutation – co-occurrences in the
sequence. The algorithm iteratively scans each position in
the sequence and searches for co-occurrences of the other
mutations mentioned in the same abstract in positions
relative to the starting one giving priority to the distance,
in terms of sequence, between al the mutations in the
same abstract instead of the exact positions provided. The
main capability of this approach is that is able to deal with
the different means in which the starting position of a pro-
tein can be defined, the most graphic case being the pres-
ence – or not – of a signal peptide but other examples can
be provided (sequencing errors or discrepancies, inclu-
sion of promoter regions, and so on. Since the finding the
profile by chance is quite easy for trivial results (the easiest
of them all being patterns consisting of just one mutation)
a limitation in the complexity of the pattern was estab-
lished, being taken into consideration only those patterns
having at least 3 mutations at different sequence posi-
tions. (2) Basic mutation to sequence position mapping:
looking up the wild type residue of an extracted mutation
mention in the corresponding protein sequence position.
(3) Alternative mutation directionality look-up: to
account for errors in the automatic extraction of the muta-
tion directionality (i.e. wild type residue with respect to
mutant residue), we examined whether the mutant resi-
due could be matched to the corresponding sequence
position. (4) Pro-peptides and mature protein mutation
mapping: to handle alternative residue counting when
signal peptide cleavage is considered we analyzed posi-
tional wild type residue mapping for cases of proteins
with N-terminal signal peptide sequences. (5) Methionine
start site counting: we carried out mutation mapping tak-
ing into account as well as neglecting the N-terminal
methionine.
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